Financials
- Market Capitalization 1.51 B
- Employee 221
- Founded 1998
- CEO Matt Kapusta
- Website www.uniqure.com
- Headquarter Netherlands
- FIGI UNKNOWN
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-6.92
Fiyat/satışlar oranı
85.48
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2125 | STOK Stoke Therapeutics, Inc. - Common Stock | 24.15 USD | -2.38% | -5.59% | -17.80% | -20.48% | 1.56 B USD | ||
| 2128 | INVA Innoviva, Inc. - Common Stock | 21.45 USD | +1.13% | +3.22% | +2.48% | +20.37% | 1.55 B USD | ||
| 2140 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 15.30 USD | -1.16% | +4.79% | +5.96% | -52.11% | 1.51 B USD | ||
| 2150 | IMCR Immunocore Holdings plc - American Depositary Shares | 29.04 USD | -1.19% | -2.97% | -12.00% | -13.26% | 1.50 B USD |